135 related articles for article (PubMed ID: 38411094)
1. Radiation-Activated Resiquimod Prodrug Nanomaterials for Enhancing Immune Checkpoint Inhibitor Therapy.
Sun J; Yao H; Ren X; Cui L; Liu L; Wang G; Tang Z
Nano Lett; 2024 Mar; 24(9):2921-2930. PubMed ID: 38411094
[TBL] [Abstract][Full Text] [Related]
2. Azide-Masked Resiquimod Activated by Hypoxia for Selective Tumor Therapy.
Sun J; Liu Z; Yao H; Zhang H; Zheng M; Shen N; Cheng J; Tang Z; Chen X
Adv Mater; 2023 Jul; 35(29):e2207733. PubMed ID: 37086177
[TBL] [Abstract][Full Text] [Related]
3. Biomineralized MnO
Deng Z; Xi M; Zhang C; Wu X; Li Q; Wang C; Fang H; Sun G; Zhang Y; Yang G; Liu Z
ACS Nano; 2023 Mar; 17(5):4495-4506. PubMed ID: 36848115
[TBL] [Abstract][Full Text] [Related]
4. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model.
Song HN; Jin H; Kim JH; Ha IB; Kang KM; Choi HS; Jeong HJ; Kim MY; Kim HJ; Jeong BK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638817
[TBL] [Abstract][Full Text] [Related]
5. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
6. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.
Zhao P; Xu Y; Ji W; Li L; Qiu L; Zhou S; Qian Z; Zhang H
Int J Nanomedicine; 2022; 17():73-89. PubMed ID: 35027827
[TBL] [Abstract][Full Text] [Related]
8. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial-based radio-immunotherapy.
Viswanath D; Park J; Misra R; Pizzuti VJ; Shin SH; Doh J; Won YY
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1924. PubMed ID: 37632203
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
11. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
[TBL] [Abstract][Full Text] [Related]
12. Host response to immune checkpoint inhibitors contributes to tumor aggressiveness.
Khononov I; Jacob E; Fremder E; Dahan N; Harel M; Raviv Z; Krastev B; Shaked Y
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707313
[TBL] [Abstract][Full Text] [Related]
13. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
14. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
15. Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
Lin W; Li C; Xu N; Watanabe M; Xue R; Xu A; Araki M; Sun R; Liu C; Nasu Y; Huang P
Int J Nanomedicine; 2021; 16():2775-2787. PubMed ID: 33880023
[TBL] [Abstract][Full Text] [Related]
16. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
17. Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy.
Guan H; Zhou Z; Hou X; Zhang F; Zhao J; Hu K
Asia Pac J Clin Oncol; 2023 Feb; 19(1):35-50. PubMed ID: 35538049
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade.
Zhang Y; Sriramaneni RN; Clark PA; Jagodinsky JC; Ye M; Jin W; Wang Y; Bates A; Kerr CP; Le T; Allawi R; Wang X; Xie R; Havighurst TC; Chakravarty I; Rakhmilevich AL; O'Leary KA; Schuler LA; Sondel PM; Kim K; Gong S; Morris ZS
Nat Commun; 2022 Aug; 13(1):4948. PubMed ID: 35999216
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
[TBL] [Abstract][Full Text] [Related]
20. Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice.
Chen JS; Hsieh YC; Chou CH; Wu YH; Yang MH; Chu SH; Chao YS; Chen CN
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]